scispace - formally typeset
Journal ArticleDOI

World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2-3 and screen-and-treat strategies to prevent cervical cancer

TLDR
It is estimated that 1%–2% of women develop cervical intraepithelial neoplasia grade 2–3 annually worldwide, and the prevalence among women living with HIV is higher, at 10%.
About
This article is published in International Journal of Gynecology & Obstetrics.The article was published on 2016-03-01. It has received 139 citations till now. The article focuses on the topics: Cervical intraepithelial neoplasia & Cervical cancer.

read more

Citations
More filters
Journal ArticleDOI

Worldwide burden of cancer attributable to HPV by site, country and HPV type.

TL;DR: The preponderant burden of HPV16/18 and the possibility of cross‐protection emphasize the importance of the introduction of more affordable vaccines in less developed countries.
Journal ArticleDOI

Carcinogenic human papillomavirus infection.

TL;DR: HPV testing will probably replace cytology-based cervical screening owing to greater reassurance when the test is negative, however, the effective implementation of HPV vaccination and screening globally remains a challenge.
Journal ArticleDOI

A review of image analysis and machine learning techniques for automated cervical cancer screening from pap-smear images.

TL;DR: An overview of the state of the art as articulated in prominent recent publications focusing on automated detection of cervical cancer from pap-smear images indicates that there are still weaknesses in the available techniques that result in low accuracy of classification in some classes of cells.
References
More filters
Journal ArticleDOI

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

TL;DR: The advantages of the GRADE system are explored, which is increasingly being adopted by organisations worldwide and which is often praised for its high level of consistency.
Journal ArticleDOI

Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.

TL;DR: There exists a substantial evidence base to support that HPV testing is advantageous both in triage of women with equivocal abnormal cytology, in surveillance after treatment of CIN lesions and in primary screening of women aged 30 years or older, however, the possible advantages offered by HPV-based screening require a well organised program with good compliance with screening and triage policies.
Journal ArticleDOI

Cytology versus HPV testing for cervical cancer screening in the general population

TL;DR: The quality of the evidence for the sensitivity of the tests was moderate, and high for the specificity, and the results did not differ by age of women (less than or greater than 30 years old), or in studies with verification bias.
Related Papers (5)